Want to join the conversation?
$ICPT 2Q15 Call: We’ll target enrollment of 1400 NASH patients with stage II/III fibrosis. After 72 weeks of treatment these patients will undergo liver biopsy & interim analysis will be performed. Histology data collected in these patients will form basis for anticipated accelerated approval filing to market OCA for treatment of NASH with fibrosis
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.